About This clinical research study
MAC is currently conducting a trial to test a new potential treatment for painful diabetic neuropathy (PDN). Diabetic neuropathy is the most common long-term complication of diabetes and is often experienced in terms of a burning, stabbing, pricking or aching sensation that is chronic and difficult to manage. The condition carries a substantial physical, social, and economic burden.
Reimbursement: Based on attended visits and up to £965
Clinics
Greater Manchester, Lancashire, Merseyside, Teesside and West Yorkshire
Therapy Area
Diabetic Neuropathy
Gender and Age
Males and Females aged 18 - 80
A full description of the study will be given before you decide to take part, both over the phone and during an appointment at a MAC clinic. This will include you receiving the full patient information sheet (PIS). Your GP will also be notified of your participation.
If you contact us, it does not mean you have to decide at that point whether to participate.
If you do decide to participate you are free to withdraw at any time.
The trial medication aims to relieve or improve the pain experienced from diabetic neuropathy. The trial medication is also currently under investigation for use in other painful conditions.
The medication or placebo will be administered intravenously, 6 times in total over 12 weeks of the 25-week trial period and is being developed to address the existing unmet need for an effective and safe treatment for this condition.
Reimbursement: Based on attended visits and up to £965
Key Inclusion Criteria
- Men and women (of non-childbearing potential) aged between 18 and 80
- Must have had painful diabetic neuropathy, in your legs or feet
- Pain not adequately controlled with current treatments
Key Exclusion Criteria
- An uncontrolled or unstable medical condition
- The use of anti-inflammatory medication during the trial e.g. ibuprofen, naproxen and any anti-inflammatory cream or gel etc
- Clinically significant osteoarthritis
Other eligibility criteria will apply. Please contact MAC for more information.
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.
ABOUT CLINICAL RESEARCH STUDIES
Clinical research studies are performed as a way of bringing about progress in medicine and research. Clinical research studies make it possible to scientifically assess the properties of a drug, to demonstrate the effectiveness and safety of a treatment or a medical device, or to learn more about a disease and methods to diagnose and monitor it.
If the study is successful, it may be an important step towards developing a promising new treatment.
MAC Clinical Research is currently conducting a trial to test a new potential treatment for painful diabetic neuropathy.
If you would like more information, please fill in the form below and we will be in touch…
Alternatively, please call our recruitment team on freephone 0800 633 5507.
Know someone who may be interested in taking part? Share this page here:
